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The patient with diabetes represents to the surgeon a particular challenge in the management
of acute abdominal problems. In addition to their ongoing and potential metabolic problems,
diabetics havespecific difficulty in their ability to handle infections and heal wounds. The pres-
ent report reviews the general principles in the peri-operative management of diabetics and
discusses the implications in the diabetic of several specific clinical problems. In view of the
known accelerated atherosclerosis associated with diabetes, the risks of anesthesia and surgery
must be assessed in the context of the coronary, cerebral, visceral, and peripheral vascular
status. Infections in diabetics (potential or established) must be treated aggressively and
promptly. Acidosis in the diabetic with abdominal pain must be considered both a metabolic
problem and a possible secondary manifestation of an intra-abdominal process. In view of
these challenges, the need for careful, anticipatory management of the diabetic patient facing
major abdominal surgery is clear.
The management of surgical problems in diabetic patients represents a common
but significant challenge. Approximately 3-4 percent ofthegeneral population is af-
fected by diabetes, and about one-halfofthem will eventually require surgery. It has
been estimated that in about one-quarter ofthe cases, the diabetes will be discovered
for the first time in the peri-operative period [1]. Advances in the understanding and
treatment of diabetes, as well as advances in anesthesia, peri-operative care, and
surgicaltechnique have dramatically improved the outcome ofoperationsperformed
in diabetics. The reported operative mortality in diabetics has decreased from as
high as 50 percent in the 1930s to a current low of under 2 percent [1,2,3,41. While a
better understanding ofthe metabolic problems in diabetics has resulted in improved
peri-operative management, diabetes continues to represent a significant risk factor
in patients with surgical problems (a factor that increases morbidity, mortality, and
the cost of health care).
We will review the pathophysiologic derangements which make surgery on the
diabetic a particular problem, emphasizing the peri-operative management of
diabetics and the role ofdiabetes as a risk factor in patients with abdominal surgical
problems.
While the underlying endocrine abnormalities in diabetes mellitus remain in-
completely defined, the diabetic state is characterized by hyperglycemia and
glycosuria secondary to a relative or absolute lack of insulin. The implications of
these changes in diabetic surgical patients are predominantly metabolic, infectious,
and vascular. Of the post-operative complication rate of 15-20 percent reported in
diabetics, about one-third are wound infections, one-third are genito-urinary or
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other infections, 10 percent are cardiovascular, and 5 percent are problems in wound
healing [1,3].
First, the diabetic is prone to metabolic decompensation in response to the stress
of either surgery, anesthesia, or the underlying condition which precipitated the
need for operation. Marked hyperglycemia, nonketotic hyperosmolar coma, and
diabetic ketoacidosis represent particular problems in the surgically stressed patient.
Second, diabetics undergoing surgery are considered to be at increased risk to
develop a significant infection. While it has been widely assumed that diabetics are
more prone to developing wound and other infections than are non-diabetics, the
clinical data are conflicting [3,5,6] and the correlation is not clearly established.
Perhaps the severity of infection in the diabetic, once established, contributes to the
impression that these patients have a higher infection rate.
Many studies have examined the increased susceptibility of diabetics to infection.
On a cellular level, it has been shown that migration of polymorphonuclear
leukocytes is delayed and phagocytosis is impaired [7] with a significant decrease of
both intracellular bacteriacidal activity of leukocytes [8] and a decrease in serum op-
sonic activity for both staphylococcus aureus and E. coli [9]. Lymphocyte activity,
as measured by response to phytohemagglutinin, is also depressed in poorly con-
trolled diabetics [10]. These abnormalities are significantly more likely in
hyperglycemic, poorly controlled diabetics and less likely when the diabetes is well-
controlled. The control of hyperglycemia and infection are interrelated in that infec-
tion leads to both hyperglycemia and acidosis which, in turn, lead to depression of
the diabetic's cellular immune system and further progression of the infection[11 ].
The third consequence of diabetes which is relevant to surgical decision making is
the accelerated development of diffuse, occlusive arteriosclerotic vascular disease.
Thickening of arteriolar and capillary vessel walls associated with dilatation of
venules is known as "small vessel disease" and is often associated with the
retinopathy, ischemic extremity ulcers, renal arteriosclerosis, and heart disease seen
in diabetics. In addition, diabetics have a significantly increased incidence of
occlusive disease in larger vessels (as a consequence of accelerated atherogenesis),
particularly in intermediate-sized muscular arteries such as the radial, tibial, and
coronary. These vascular lesions account for a significant percentage of the post-
operative morbidity and mortality in patients undergoing abdominal surgery.
DIABETES MANAGEMENT
Surgical management in the diabetic must be directed toward anticipating and ag-
gressively treating both hyperglycemia and acidosis, while avoiding hypoglycemia.
If the diabetes is unrecognized or inappropriately treated, severe acidosis may
develop in the post-operative period. With the diabetic's abnormal glucose utiliza-
tion, endogenous fat and protein are metabolized to provide calories to meet energy
needs. Acidosis results from the accumulation of ketone bodies with a reduction in
both plasma bicarbonate and blood pH. As the post-operative energy demands in-
crease, the catabolism of fat and protein as well as the acidosis increase. Con-
comitantly, there is an increase in the blood sugar(with the baseline glucose in-
tolerance often compounded by an increased peri-operative output of epinephrine);
this hyperglycemia (if not corrected) will lead to an osmotic diuresis, severe ex-
tracellular fluid deficit, and potentially life-threatening acidosis. It requires ag-
gressive treatment with insulin, bicarbonate, and intravenous fluid (usually
hypotonic salt solutions).
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The pre-operative evaluation of the diabetic patient should particularly focus on
an assessment of: (a) the severity of the diabetes and the adequacy of its control (oral
hypoglycemics or insulin, a history of ketoacidosis or hyperosmolar coma), and (b)
the significance of associated cardiac or vascular problems.
While a variety of treatment regimens have been recommended and are effective,
the goal in the peri-operative management of the diabetic patient is to maintain a
relative steady state of glucose metabolism with the blood sugar between 100-250
mg%o. Mild to moderate hyperglycemia and glycosuria is better tolerated (and safer)
than hypoglycemia. For the insulin-dependent diabetic undergoing elective surgery,
the smoothest control with the minimal catabolism results from continued treatment
with intermediate acting forms of insulin (NPH or lente insulin, usually at one-half
the normal dose, given in the morning before surgery) with supplementation by
regular, subcutaneous insulin (dose best determined by four-to-six-hour monitoring
of the blood sugar). A glucose-containing infusion as well as glucose monitoring
should obviously be continued intra-operatively as well [1].
In the diabetic patient who requires emergency surgery, extended pre-operative
preparation is obviously not possible. In these instances, it is important to correct
any existing acidosis and to control the hyperglycemia with insulin as well as possible
before surgery. The need for adequate fluid resuscitation and correction of elec-
trolyte abnormalities is obvious and fundamental. Surgery should be performed
expeditiously, but the risks of operating on a patient who is hemodynamically and
metabolically unstable usually make a delay of afew hours justifiable.
Post-operatively, these patients will often have a significant amelioration of their
diabetes, and care must be taken not to allow the patient to become hypoglycemic
from overly vigorous insulin therapy.
COMPLICATIONS
The majority of surgical complications in diabetics fall into two categories: infec-
tious and cardiovascular. Accelerated atherosclerosis accounts for the high in-
cidence of myocardial infarction and stroke in these patients. Pratt reported that
two-thirds of the diabetic surgical mortality in his series was secondary to car-
diovascular complications [12]. Infectious complications are prominently mentioned
in most series [3,13,14,15] despite advances in sterility, technique, and antibiotic
therapy. Other significant complications (e.g., pulmonary embolus, GI hemorrhage,
pneumonia) occur with about the same frequency as in non-diabetics.
DIABETES AND THE GI TRACT
There are numerous gastrointestinal manifestations of diabetes mellitus. Though
they are of varying surgical importance, they will be mentioned briefly.
Esophageal dysfunction, though rarely a source of complaint in the diabetic, has
been detected radiographically and manometrically. The abnormalities observed in-
clude decreased peristalsis, delayed esophageal emptying, and low UES pressure.
Poor gastric emptying and associated motor dysfunction occurs in as many as 30
percent of patients with diabetes [16]. "Gastroparesis diabeticorum" can cause
delayed emptying, a sense of fullness, and, often, a marked difficulty in controlling
the diabetes itself, as food is not delivered to the small bowel at a reliable rate.
Surgical drainage procedures (e.g., gastroenterostomy or pyloroplasty) have been
attempted for some time with equivocal results [17].
Recent evidence suggests that metoclopramide will improve both gastric emptying
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and the symptoms of gastric stasis in some of these diabetic patients [18]. Patients
who fail metoclopramide therapy continue to be a major surgical challenge.
Diabetics also have an increased incidence of parietal cell antibodies, mucosal
atrophy, and pernicious anemia [19].
Constipation in the diabetic is felt to be secondary to an autonomic neuropathy
although it rarely reaches surgical attention. Diarrhea has been reported in up to 7
percent of diabetic patients and may also be attributable to a neuropathy and
secondary bacterial overgrowth; the evidence for this is, however, equivocal.
PANCREAS
It has been suggested that there is a higher incidence of pancreatitis in diabetics
than in non-diabetics. A large autopsy series reported an incidence ofpancreatitis of
11.2 percent in diabetics as opposed to 5.3 percent in non-diabetics. These findings
were attributed to occlusive vascular lesions noted in the arteries supplying the pan-
creas of the diabetics [20]. Whether this interesting, apparent difference is clinically
relevant remains unproven. The incidence of pancreatic carcinoma has been
reported to be twice as high in the diabetic as in the non-diabetic [21]. The reason for
this is unknown. The surgical approach to both these diseases is similar to that in the
non-diabetic.
PEPTIC ULCER DISEASE
Gastric ulcer appears to occur with the same frequency in diabetic and non-
diabetic populations. Duodenal ulcer has, however, been reported to have a lower
incidence in diabetics. This negative correlation is not well understood but may be
due to the neuropathy which creates an "autovagotomy" resulting in decreased acid
secretion [22]. Complications of duodenal ulcer, are, however, more frequent and
severe in diabetics [2].
BILIARY TRACT
The question of a positive association between cholelithiasis and diabetes remains
controversial and unconfirmed. It has been reported that the autopsy incidence of
gall stones is about 30 percent in diabetics as compared to 20 percent in non-
diabetics [23]. Any significant increase in the incidence of gall stones in diabetics
may, however, be related more to obesity and hypercholesterolemia than to the
diabetes itself. While the presence ofdiabetes has not been clearly shown to increase
the likelihood ofcholecystitis in apatient with gall stones, it has been repeatedly sug-
gested that acute cholecystitis has a more fulminant course and graver prognosis in
diabetics. Mortality rates of between 11 and 22 percent have been reported in
diabetic patients with acute cholecystitis as compared to a mortality of less than 1
percent in non-diabetics. Emergency cholecystectomy in this setting has resulted in
an operative mortality in diabetics as high as 20 percent with a 50 percent post-
operative complication rate [14,15,23].
In addition, it has been noted that the infectious and necrotizing components of
acute cholecystitis are more rapidly progressive in diabetics, with some series report-
ing an incidence ofnecrosis of the gall bladder wall as high as 70 percent in patients
undergoing cholecystectomy [14]. Perforation and gangrene can be seen within 24
hours of the onset of symptoms. The explanation for this is unclear, as there is no
evidence of vascular insufficiency or neuropathy in the gall bladder bed ofthese pa-
tients. Also, there is no glucose in human bile, so the argument cannot be made (as
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in the urinary tract) that bacterial overgrowth progresses more rapidly in diabetic
bile. While these data are alarming and have significantly affected surgical decision
making in the diabetic patient with biliary tract disease, more recent studies have
raised important questions about these past conclusions [24]. Whether this increased
morbidity and mortality is related to the diabetes alone or whether it results from the
increased incidence of obesity, vascular disease, and renal disease seen in diabetics
remains unresolved. It seems probable that there is a sub-group of patients with
complications of their diabetes in whom both acute cholecystitis and biliary tract
surgery represent a significantly increased risk while the results in uncomplicated
diabetics may well approach those in normals. In view of the data currently available
most authors agree that cholelithiasis in the diabetic (even if asymptomatic) should
be treated by elective cholecystectomy. An emergency cholecystectomy is indicated
if an episode of acute cholecystitis does not rapidly resolve with medical manage-
ment.
APPENDICITIS
There is little in the literature regarding the association of diabetes with other ab-
dominal surgical conditions. One series of 60 cases of diabetics undergoing surgery
for acute appendicitis reported a "strikingly large number of patients with atypical
appendicitis." These patients often presented with atypical signs and symptoms,
such as absence of pain or leukocytosis, which delayed diagnosis and operation [25].
MESENTERIC VASCULAR DISEASE
In view of the accelerated atherosclerotic vascular disease seen in diabetics,
mesenteric ischemia and its complications should always be considered by the physi-
cian treating an older diabetic patient with abdominal complaints, especially if the
patient has co-existing coronary, cerebral, or peripheral vascular disease. Acute
mesenteric ischemia is a diagnostic and therapeutic challenge in diabetics as well as
non-diabetics. Its etiology may be arterial or venous, occlusive or non-occlusive.
The arterial occlusion may be caused by an in situ thrombosis of an already diseased
and stenotic vessel or an embolus dislodged from some proximal site in the arterial
tree; non-occlusive ischemia is associated with low-flow states and results in diffuse,
splanchnic vasoconstriction (most often in a setting marked by congestive heart
failure, hypovolemia, or vasoconstrictive agents like digitalis). Patients with acute
mesenteric ischemia rarely develop significant abdominal findings (peritoneal signs)
prior to the development of full-thickness intestinal necrosis and gangrene. The ob-
vious clinical challenge is to make the diagnosis prior to this stage of irreversible
infarction and institute therapy that will stop the progression of the ischemia. In a
patient whose symptoms develop in a clinical setting compatible with mesenteric
ischemia and who is having severe abdominal pain that is out of proportion to the
physical findings (and not readily explainable on a non-vascular basis) angiographic
confirmation of the diagnosis of mesenteric ischemia should be sought. If non-
occlusive ischemia is confirmed angiographically by the finding of diffuse, splanch-
nic vasoconstriction, superior mesenteric artery perfusion with vasodilating agents
(e.g., papaverine) should be instituted. If an arterial occlusion is documented, the
need for surgical intervention should be guided by the clinical evidence of ongoing
ischemia. For patients who come to surgery, all infarcted bowel must be resected;
revascularization should be undertaken to preserve the marginally perfused but
reversibly ischemic intestine (embolectomy if the etiology is embolic; bypass if there
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has been thrombosis of a stenotic arterial segment). The challenge to the surgeon lies
in early intervention (before extensive ischemia mandates massive resection) and in
accurately assessing the extent of viability (realizing that the serosal surface of the
bowel is the last of the bowel layers to become ischemic). It is obvious that the cost
of a late or missed diagnosis is high: the outlook is grim, indeed, for an elderly,
diabetic patient with diffuse atherosclerosis in whom the only therapeutic alternative
is an emergency massive intestinal resection for extensive and irreversible ischemia.
DIABETIC ACIDOSIS AND ABDOMINAL PAIN
A confusing aspect of surgical diagnosis in the diabetic with abdominal com-
plaints is the presence of acidosis. While acidosis can be precipitated by an acute
surgical intra-abdominal condition, diabetic ketoacidosis alone often presents with
abdominal complaints and indeed can mimic an acute abdomen (with pain, nausea,
and vomiting associated with signs ofperitoneal irritation). These patients may also
have a significant leukocytosis. Attempts to rule out significant intra-abdominal
pathology can be extremely difficult. In these cases, several approaches may be
helpful. A careful history obtained from the patient or his family may indicate an
intra-abdominal condition that existed before the onset of symptoms (such as gall
stones, diverticulosis, or peptic ulcer disease). The sequence of symptoms may be
helpful. Diabetic acidosis usually presents with nausea and vomiting, followed by
pain (often upper abdominal), and sometimes drowsiness, and dyspnea. This is in
contrast to the characteristic presentation ofmany intra-abdominal conditions, par-
ticularly appendicitis, in which the pain usually precedes the nausea and vomiting.
The evaluation of the patient should proceed at the same time the diabetes and
acidosis are being appropriately treated. Abdominal findings secondary to acidosis
alone should improve with correction of the acidosis. If they do not improve and
signs of peritonitis persist, surgery is usually indicated. Allowing several hours to
treat the underlying acidosis is not only of diagnostic value but, as mentioned
previously, is mandatory in the event that the patient subsequently requires surgery.
In a reported series of 211 episodes of severe diabetic metabolic decompensation,
46 patients (22 percent) had associated severe abdominal pain and tenderness. In
seventeen ofthese(37 percent) an intra-abdominal source for the pain and metabolic
decompensation was found. In these cases the location of the pain correlated fairly
well with its source except in pyelonephritis, which had a variable presentation. The
two cases ofappendicitis in the series presented with right lower quadrant pain. The
episodes of abdominal pain for which an abdominal source was never found all oc-
curred in insulin-dependent diabetics less than forty years of age. In these patients
only three had a plasma bicarbonate of greater than 10 mEq/liter. The authors
conclude that "abdominal pain occurring in patients more than forty years old, ir-
respective of the plasma bicarbonate level, and in patients of any age with a plasma
bicarbonate level in excess of 10 mEq/liter, almost invariably indicates a specific
underlying cause" [26]. Theseguidelines, in addition to frequent re-evaluation of the
patient during treatment of acidosis, should help define those patients requiring
early exploration for an acute intra-abdominal problem [27].
SUMMARY
Diabetes has significant implications both as a risk factor in patients undergoing
surgery and as a factor affecting the pathogenesis of a variety of intra-abdominal
conditions. The management of diabetes and its complications is a common part of
any surgical practice. Aside from the life-threatening metabolic derangements which
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can occur in diabetics with surgical problems, surgical decision making is particu-
larly affected by an awareness of the diabetics' propensity toward infection and ac-
celerated atherogenesis. Because of these, the incidence of surgical complications in
diabetics is significantly higher than that in non-diabetics. Careful, anticipatory
management of the diabetic patient in the peri-operative period is essential to
minimizing these complications.
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